A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinomaHanjie Yi, Da-Jun Yang, Luping Yuan et al.|Journal of Experimental & Clinical Cancer Research|2018Cited by 71
A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancerSi Shi, Xianjun Yu, Jian Zhang et al.|Cell Reports Medicine|2025Cited by 1